Defibrillators Market Surges to USD 20.2 Billion by 2030, Reflecting an 6.7% Growth | MarketDigits
The Global Defibrillators Market was valued USD 12.0 Billion in 2023 and projected to reach USD 20.2 Billion by 2030, growing at a CAGR of 6.7% during the forecast period of 2023-2030
Richmond, Feb. 13, 2024 (GLOBE NEWSWIRE) -- According to a research report "*Defibrillators Market”*,* by* *Product Type (Implantable Defibrillators, {Transvenous Implantable Cardioverter Defibrillator (T-ICDs), Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs), Cardiac Resynchronization Therapy- Defibrillator (CRT-D)}, External Defibrillators, {Manual External Defibrillator, Automated External Defibrillator (AEDs), Wearable Cardioverter Defibrillator (WCDs)}), Distribution Channel (Hypermarkets and Supermarkets, Conventional Store, Online, Subscription Model, Others) and Region - Global Forecast to 2030.*
*Global Defibrillators Market* *Report Scope:*
*Report* *Details*
*Market size value in 2023* *USD 12.0 Billion*
*Market size value in 2030* *USD 20.2 Billion*
*CAGR (2023-2030)* *6.7%*
*Forecast Period* *2023–2030*
*Historic Data* *2019*
*Forecast Units* *Value (USD Million/USD Billion)*
*Segments Covered* *Product Type**, Distribution Channel, End User and Region*
*Geographies Covered* *North America, Europe, Asia Pacific, and RoW*
* * · *Medtronic*
· *Abbott*
*Sample of Companies Covered * · *AMI Italia*
· *BIOTRONIK SE & Co. KG*
· *Boston Scientific Corporation*
*Download the Sample* - *https://www.marketdigits.com/request/sample/4054*
*TOC Covers in Depth & Breath on **Defibrillators Market*
*170 - Market Data Tables *
*65 - List of Figures*
*225 – Pages*
The report includes Vendor Assessment (Company Profiles, Market Positioning, Strategies, Recent Developments, Capabilities & Product Offerings / Mapping), Technology Assessment (Developments & Economic Impact), Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional FootPrint by MarketDigits*.*
*Market Overview*
The Global Defibrillators market occupies an essential role in the contemporary health industry, in defibrillation technology have led to the utilization of various devices, including the transvenous implantable cardioverter-defibrillator (ICD) including or excluding cardiac resynchronization therapy, the subcutaneous ICD (S-ICD), and the wearable cardioverter-defibrillator. To ensure optimal device utilization and achieve favorable patient outcomes, clinicians must comprehend the functionality of these devices, understand the patient characteristics suitable for each type, and identify existing knowledge gaps. The transvenous ICD has demonstrated efficacy in improving the survival of patients experiencing near-fatal ventricular fibrillation or sustained ventricular tachycardia with syncope or systolic heart failure due to ischemic or nonischemic cardiomyopathy. However, gaps in knowledge persist regarding the ICD's role in specific patient subgroups not well-represented in clinical trials, necessitating refinement of selection criteria.
Subcutaneous ICDs, introduced as an alternative to transvenous ICDs, offer a lower risk of infection and lead-related complications but lack bradycardia or antitachycardia pacing. While ideal for patients with limited vascular access, high infection risk, or certain congenital heart diseases, further data are required to assess S-ICD efficacy, defibrillation testing needs, and its compatibility with other emerging technologies.
*Major Vendors in the Global Defibrillators Market:*
· Medtronic
· Abbott
· AMI Italia
· BIOTRONIK SE & Co. KG
· Boston Scientific Corporation
· BPL Medical Technologies
· Koninklijke Philips N.V.
· LivaNova PLC
· MicroPort Scientific Corporation
· Mindray Medical International Limited
· Nihon Kohden Corporation
· Schiller AG
· Stryker
· ZOLL Medical Corporation (Asahi Kasei)
*Request for Discount @ https://www.marketdigits.com/request/discount/4054 *
*Increased awareness about the prevalence of sudden cardiac arrest*
One of the primary drivers for the global Defibrillators market is the significant increased awareness about the prevalence of sudden cardiac arrest is a key factor driving the utilization of defibrillators. People are becoming more informed about the frequency of sudden cardiac arrest incidents and the critical role that defibrillators play in saving lives during these emergencies. This heightened awareness has led to greater advocacy for the placement of defibrillators in various public spaces and institutions, as individuals recognize the importance of quick access to these life-saving devices in potentially life-threatening situations. The emphasis on public education and awareness campaigns has contributed to a broader understanding of the significance of defibrillators in improving outcomes for individuals experiencing sudden cardiac arrest.
*Market Dynamics*
*Drivers:*
· Growing focus on providing public-access defibrillator
· Growing prevalence of cardiovascular diseases
· Increased awareness about the prevalence of sudden cardiac arrest
· Availability of training programs in cardiopulmonary resuscitation
*Opportunities:*
· Technological Advancements
· Health and Wellness Trends
· E-commerce Growth
· Globalization and Cultural Diversity
*Advancements in defibrillators Processing Technologies*
Technological advancements in defibrillators have significantly improved their effectiveness, usability, and overall capabilities. Automated External Defibrillators (AEDs) have become more prevalent, offering user-friendly interfaces that guide even non-medical personnel through the defibrillation process. Voice prompts, visual cues, and automated analysis of the patient's heart rhythm contribute to simplified operation. Integration with smart technologies allows defibrillators to connect to mobile applications or cloud platforms. This connectivity enables remote monitoring, automatic updates, and data sharing, facilitating real-time communication with emergency services or healthcare providers. Modern defibrillators provide real-time feedback on the quality of cardiopulmonary resuscitation (CPR) being administered. This includes guidance on chest compression depth, rate, and proper ventilation techniques, helping users optimize their life-saving efforts. Biphasic waveform technology in defibrillators has become standard. This technology delivers electrical shocks in two phases, improving the success rate of defibrillation and minimizing potential damage to the heart.
*North America dominates the market for Defibrillators.*
North America stands out as the dominating region in the global Defibrillators market, with the United States leading in consumption and market share. The significant occurrence of cardiovascular diseases, growing acceptance of technologically advanced defibrillator products, and the involvement of major players in the market contribute to its dynamics. The U.S. market particularly benefits from a diverse consumer base with a penchant for quick and convenient meal options.
Asia-Pacific, and specifically India, is emerging as a key player with substantial growth potential in the Defibrillators market. The creation of sophisticated products to address the increasing demand for defibrillators is anticipated to be a driving factor for market expansion. India's market is driven by a rising urban population, increasing disposable incomes, and a shift towards Westernized habits. The convenience factor aligns well with the fast-paced urban life in countries like India, making defibrillators increasingly popular. Additionally, government initiatives promoting the health processing sector and improvements in distribution channels contribute to the market's growth.
Another noteworthy region is the Middle East and Africa, where the demand for convenient health solutions is on the rise due to changing lifestyles and an expanding working-class population. South Africa, in particular, showcases promise as a market with high growth potential, driven by urbanization and a growing awareness of convenient health options.
*Inquire Before Buying:* *https://www.marketdigits.com/request/enquiry-before-buying/4054 *
*The Transvenous Implantable Cardioverter Defibrillator (T-ICDs) Segments is anticipated to hold the Largest Market Share during the Forecast Period*
In the global Defibrillators market, The T-ICD is surgically implanted in the patient's chest or upper abdomen. It consists of a pulse generator and one or more leads that are threaded through veins into the heart. The device continuously monitors the heart's rhythm. If it detects a potentially life-threatening arrhythmia, it delivers an electric shock to restore normal heart rhythm. In the event of a dangerous ventricular arrhythmia, the T-ICD delivers a therapeutic shock to the heart. This shock, also known as defibrillation, interrupts the abnormal rhythm and allows the heart to resume a normal, coordinated beat. Some T-ICDs also have a pacing function. If the heart rate is too slow, the device can send small electrical impulses to stimulate the heart and maintain an appropriate heart rate.
*Segmentations Analysis of Defibrillators Market: -*
· *By Product Type*
· · Implantable Defibrillators
· Transvenous Implantable Cardioverter Defibrillator (T-ICDs)
· Subcutaneous Implantable Cardioverter Defibrillator (S-ICDs)
· Cardiac Resynchronization Therapy- Defibrillator (CRT-D)
· External Defibrillators
· Manual External Defibrillator
· Automated External Defibrillator (AEDs)
· Wearable Cardioverter Defibrillator (WCDs)
· *By End-user*
· Hospitals clinics & Cardiac centre
· Prehospital care setting
· Public access market
· Alternative care facilities
· Home care setting
· Others
· *By Distribution Channel*
· Hypermarkets and Supermarkets
· Conventional Store
· Online
· Subscription Model
· Others
· *By Region *
· North America
· Latin America
· Europe
· Asia Pacific
· Middle East & Africa
*Elevate Your Business Strategy! Purchase the Report for Market-Driven Insights @ https://www.marketdigits.com/checkout/4054?lic=s *
*Browse Similar Reports:*
*Cardiac Marker Testing Market *2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
*Cardiac Biomarker Diagnostic Test Kits Market *2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
*Cardiac Surgery Instruments Market* 2030 By Type, Distribution Channel, End-user and Region - Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits
*About MarketDigits:*
MarketDigits is one of the leading business research and consulting companies that helps clients to tap new and emerging opportunities and revenue areas, thereby assisting them in operational and strategic decision-making. We at MarketDigits believe that a market is a small place and an interface between the supplier and the consumer, thus our focus remains mainly on business research that includes the entire value chain and not only the markets.
We offer services that are most relevant and beneficial to the users, which help businesses to sustain themselves in this competitive market. Our detailed and in-depth analysis of the markets catering to strategic, tactical, and operational data analysis & reporting needs of various industries utilize advanced technology so that our clients get better insights into the markets and identify lucrative opportunities and areas of incremental revenues.
*Contact Us:*
*MarketDigits*
1248 CarMia Way Richmond,
VA 23235,
United States.
USA: +1 847 450 0808
*Email:* sales@marketdigits.com
*Web*: https://www.marketdigits.com
*Follow Us on: | **Twitter** | **LinkedIn** |*